Form 8-K CAPRICOR THERAPEUTICS, For: Aug 15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
Capricor Therapeutics (CAPR) Misses Q2 EPS by 2c
August 15, 2016 4:45 PM EDTCapricor Therapeutics (NASDAQ: CAPR) reported Q2 EPS of ($0.26), $0.02 worse than the analyst estimate of ($0.24).
For earnings history and earnings-related data on Capricor Therapeutics (CAPR) click here.
... More